APA (7th ed.) Citation

Cai, R., Lu, B., Zhao, X., Zhou, S., & Li, Y. iPSC-derived NK cells engineered with CD226 effectively control acute myeloid leukemia. BMC.

Chicago Style (17th ed.) Citation

Cai, Runze, Binyan Lu, Xiangyu Zhao, Shixin Zhou, and Yang Li. IPSC-derived NK Cells Engineered with CD226 Effectively Control Acute Myeloid Leukemia. BMC.

MLA (9th ed.) Citation

Cai, Runze, et al. IPSC-derived NK Cells Engineered with CD226 Effectively Control Acute Myeloid Leukemia. BMC.